MedPath

Prospective Athlete's Heart Study

Recruiting
Conditions
Athlete Heart
Interventions
Other: No intervention
Registration Number
NCT05164328
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

The Pro@Heart (Prospective Athlete's Heart) study is an international multicentre long-term prospective trial. The primary objective of the Pro@Heart study is to investigate the impact of training load (i.e. accurately evaluated in term of type, frequency, duration and intensity) and genotype on the variability of structural, functional and electrical exercise induced cardiac remodeling (EICR) in young competitive endurance athletes. The second objective is to determine how EICR, training load and genotype are associated with physical performance, health benefits and cardiac pathology (e.g. exercise-related cardiomyopathies and arrhythmias) during follow-up over several decades.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
450
Inclusion Criteria
  1. Males and females aged 14-23 years old

  2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include:

    1. Triathlon
    2. Cycling
    3. Distance running (≥ 1500 meters)
    4. Rowing
    5. Swimming
  3. Non athletes engaged in < 3 hours per week of physical activity

Exclusion Criteria
  1. Medical history of cardiovascular disease
  2. Current smoker of past history of smoking
  3. Diabetes mellitus

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
AthletesNo intervention1. Males and females aged 14-23 years old 2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include: 1. Triathlon 2. Cycling 3. Distance running (≥ 1500 meters) 4. Rowing 5. Swimming
Non-athletesNo intervention1. Males and females aged 14-23 years old 2. Non athletes engaged in \< 3 hours per week of physical activity
Primary Outcome Measures
NameTimeMethod
GenotypeBaseline

Rare and common variants in cardiomyopathy associated genes

Atrial fibrillationBaseline to 20 years
Ventricular arrhythmiasBaseline to 20 years

Ventricular ectopic beats, non-sustained and sustained ventricular tachycardia

Training loadBaseline to 20 years

Duration and intensity of training

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Jessa Ziekenhuis Hasselt

🇧🇪

Hasselt, Limburg, Belgium

Baker Heart and Diabetes Institute

🇦🇺

Melbourne, Victoria, Australia

UZ Antwerpen

🇧🇪

Edegem, Antwerp, Belgium

UZ Leuven

🇧🇪

Leuven, Vlaams Brabants, Belgium

© Copyright 2025. All Rights Reserved by MedPath